Cala Introduces Next Generation System and Accelerates Leadership in Bioelectronic Medicine
CALADelisted Stock | USD 0.05 0.00 0.00% |
About 56% of Calithera Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Calithera Biosciences pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Calithera Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Calithera Biosciences stock news signals to limit their universe of possible portfolio assets.
Calithera |
SAN MATEO, Calif., April 19, 2023--Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, will preview the next generation of its wearable neuromodulation system and the results of two studies at the 2023 American Academy of Neurology Annual Meeting, held from April 22-27, 2023, in Boston, MA.
Read at finance.yahoo.com
Calithera Biosciences Fundamental Analysis
We analyze Calithera Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calithera Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calithera Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Calithera Biosciences is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Calithera Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calithera Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Calithera Biosciences could also be used in its relative valuation, which is a method of valuing Calithera Biosciences by comparing valuation metrics with similar companies.
Peers
Calithera Biosciences Related Equities
VSTM | Verastem | 16.85 | ||||
HEPA | Hepion Pharmaceuticals | 4.69 | ||||
ADVM | Adverum Biotechnologies | 2.95 | ||||
CKPT | Checkpoint Therapeutics | 2.57 | ||||
LPTX | Leap Therapeutics | 2.05 | ||||
PDSB | PDS Biotechnology | 1.86 | ||||
KOD | Kodiak Sciences | 1.83 | ||||
ZURA | Zura Bio | 1.67 | ||||
MREO | Mereo BioPharma | 1.40 | ||||
ABEO | Abeona Therapeutics | 0.31 | ||||
GLMD | Galmed Pharmaceuticals | 0.35 | ||||
ARDX | Ardelyx | 0.35 | ||||
AFMD | Affimed NV | 1.05 | ||||
ADAP | Adaptimmune Therapeutics | 1.37 | ||||
PIRS | Pieris Pharmaceuticals | 3.45 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |